At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
Vascular Reconstruction Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The SUNRISE Registry - A Multicenter Post-Market Surveillance With the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System
In Brief
An observational study evaluating Vascular Reconstruction Device for Intracranial Aneurysm. Completed, enrolled 105 participants across 1 site.
Detailed Summary
The objective of the registry is to evaluate the real world safety and performance of the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System (VRD) to facilitate endovascular coil embolization of intracranial aneurysms.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysm
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2007
First PostedJun 2007
Primary CompletionDec 2012
Study CompletionDec 2013
TodayJul 2026
First PostedJun 14, 2007
Enrollment StartJun 1, 2007
Primary CompletionDec 1, 2012
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 19.1 years ago
Interventions
Vascular Reconstruction Devicedevice
CORDIS ENTERPRISE™ VRD